SCOTT KIM: Open Payments
NPI 1164650461 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,573 in 133 payments from 21 companies in 2025. Trend: 2023 $2,106 · 2024 $2,703 · 2025 $2,573
Food & beverage: $2,573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $453 |
| ANI Pharmaceuticals, Inc. | 17 | $427 |
| Boston Scientific Corporation | 26 | $249 |
| BIOTRONIK NRO, Inc. | 3 | $214 |
| PFIZER INC. | 13 | $165 |
| Neurocrine BioSciences, Inc. | 6 | $159 |
| Collegium Pharmaceutical, Inc. | 11 | $158 |
| MML US, Inc. | 4 | $153 |
| Lundbeck LLC | 5 | $110 |
| Axsome Therapeutics, Inc. | 4 | $97 |
Products named: PURIFIED CORTROPHIN GEL, QULIPTA, Prospera, WaveWriter Alpha Prime 16, INGREZZA, Belbuca, ReActiv8, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
